{"id":40744,"date":"2026-10-29T11:34:09","date_gmt":"2026-10-29T11:34:09","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=40744"},"modified":"2026-10-29T11:34:09","modified_gmt":"2026-10-29T11:34:09","slug":"hutchmed-wins-fda-orphan-drug-status-for-sovleplenib","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/","title":{"rendered":"HUTCHMED\u3001\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u306b\u3064\u3044\u3066FDA\u304b\u3089\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d6\u5f97\u3057\u305f"},"content":{"rendered":"<?xml encoding=\"utf-8\" ?><p>\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u306f\u3001\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u307e\u305f\u306fITP\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u3001\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u306b\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u4e0e\u3048\u305f\u3002HUTCHMED Limited\u306f2026\u5e7410\u670828\u65e5\u3001\u3053\u306e\u6c7a\u5b9a\u3092\u767a\u8868\u3057\u305f\u3002ITP\u306f\u3001\u8840\u5c0f\u677f\u6570\u304c\u6e1b\u5c11\u3057\u3066\u51fa\u8840\u306e\u30ea\u30b9\u30af\u304c\u9ad8\u307e\u308b\u75be\u60a3\u3067\u3042\u308b\u3002.<\/p><p>\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u306f\u3001HUTCHMED\u304c\u958b\u767a\u4e2d\u306e\u533b\u85ac\u54c1\u3067\u3042\u308b\u3002\u3053\u308c\u306f\u3001\u813e\u81d3\u30c1\u30ed\u30b7\u30f3\u30ad\u30ca\u30fc\u30bc\uff08Syk\uff09\u306e\u7d4c\u53e3\u963b\u5bb3\u5264\u3067\u3042\u308b\u3002\u3053\u306e\u85ac\u306f1\u65e51\u56de\u306e\u670d\u7528\u3092\u60f3\u5b9a\u3057\u3066\u8a2d\u8a08\u3055\u308c\u3066\u3044\u308b\u3002\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u306f\u3001\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u306e\u958b\u767a\u306b\u304a\u3051\u308b\u91cd\u8981\u306a\u7bc0\u76ee\u3067\u3042\u308b\u3002.<\/p><p>FDA\u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u3001\u7279\u5b9a\u306e\u75be\u60a3\u306b\u5bfe\u3059\u308b\u533b\u85ac\u54c1\u306e\u958b\u767a\u3092\u4fc3\u9032\u3059\u308b\u3082\u306e\u3067\u3042\u308b\u3002\u5bfe\u8c61\u3068\u306a\u308b\u306e\u306f\u3001\u7c73\u56fd\u306720\u4e07\u4eba\u4ee5\u4e0a\u306b\u5f71\u97ff\u3092\u53ca\u307c\u3059\u75be\u60a3\u3067\u3042\u308b\u3002\u3053\u306e\u6307\u5b9a\u306f\u3001\u5f53\u8a72\u533b\u85ac\u54c1\u304c\u4f7f\u7528\u627f\u8a8d\u3055\u308c\u305f\u3053\u3068\u3092\u610f\u5473\u3059\u308b\u3082\u306e\u3067\u306f\u306a\u3044\u3002\u307e\u305f\u3001\u305d\u306e\u533b\u85ac\u54c1\u304c\u4e00\u822c\u306e\u4eba\u3005\u306b\u3068\u3063\u3066\u5b89\u5168\u3067\u3042\u308b\u3001\u3042\u308b\u3044\u306f\u6709\u52b9\u3067\u3042\u308b\u3068\u3044\u3046\u610f\u5473\u3067\u3082\u306a\u3044\u3002 \u305f\u3060\u3057\u3001\u5e0c\u5c11\u75be\u60a3\u306e\u6cbb\u7642\u85ac\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u4f01\u696d\u306b\u306f\u3001\u4e00\u5b9a\u306e\u30e1\u30ea\u30c3\u30c8\u304c\u3082\u305f\u3089\u3055\u308c\u308b\u3002.<\/p><p>\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u306e\u5834\u5408\u3001\u3053\u308c\u3089\u306e\u30e1\u30ea\u30c3\u30c8\u306b\u306f\u3001\u6307\u5b9a\u3055\u308c\u305f\u9069\u5fdc\u75c7\u306b\u3064\u3044\u3066\u627f\u8a8d\u3055\u308c\u305f\u5834\u5408\u306b\u3001\u7c73\u56fd\u30677\u5e74\u9593\u306e\u5e02\u5834\u72ec\u5360\u6a29\u304c\u5f97\u3089\u308c\u308b\u3053\u3068\u304c\u542b\u307e\u308c\u308b\u3002\u307e\u305f\u3001\u4e00\u5b9a\u306e\u57fa\u6e96\u3092\u6e80\u305f\u3059\u81e8\u5e8a\u8a66\u9a13\u306b\u5bfe\u3059\u308b\u7a0e\u984d\u63a7\u9664\u3082\u542b\u307e\u308c\u308b\u3002\u3055\u3089\u306b\u3001\u533b\u85ac\u54c1\u958b\u767a\u4f01\u696d\u306f\u3001FDA\u306e\u4f7f\u7528\u6599\u306e\u4e00\u90e8\u306b\u3064\u3044\u3066\u514d\u9664\u3092\u53d7\u3051\u308b\u53ef\u80fd\u6027\u3082\u3042\u308b\u3002\u958b\u767a\u671f\u9593\u4e2d\u306f\u3001FDA\u304b\u3089\u306e\u5c02\u9580\u7684\u306a\u6307\u5c0e\u3092\u53d7\u3051\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002.<\/p><h3>\u539f\u767a\u6027\u514d\u75ab\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u306e\u7406\u89e3<\/h3><p>ITP\u306f\u3001\u514d\u75ab\u7cfb\u304c\u8840\u5c0f\u677f\u3092\u653b\u6483\u3057\u3066\u7834\u58ca\u3057\u3001\u3055\u3089\u306b\u8840\u5c0f\u677f\u306e\u751f\u6210\u3082\u6b62\u3081\u3066\u3057\u307e\u3046\u3053\u3068\u3067\u767a\u75c7\u3059\u308b\u3002\u8840\u5c0f\u677f\u306f\u8840\u6db2\u51dd\u56fa\u306b\u4e0d\u53ef\u6b20\u3067\u3042\u308b\u305f\u3081\u3001ITP\u306e\u60a3\u8005\u306f\u3042\u3056\u304b\u3089\u5927\u91cf\u306b\u51fa\u8840\u3057\u305f\u308a\u3001\u305d\u306e\u4ed6\u306e\u554f\u984c\u306b\u60a9\u307e\u3055\u308c\u305f\u308a\u3059\u308b\u3053\u3068\u304c\u3042\u308b\u3002ITP\u306f\u75b2\u52b4\u611f\u3092\u5f15\u304d\u8d77\u3053\u3059\u3053\u3068\u3082\u3042\u308b\u3002ITP\u306f\u751f\u6d3b\u306e\u8cea\u3092\u4f4e\u4e0b\u3055\u305b\u308b\u3002\u79c1\u306f\u3001ITP\u306b\u3088\u3063\u3066\u65e5\u5e38\u306e\u4f5c\u696d\u304c\u3069\u308c\u307b\u3069\u56f0\u96e3\u306b\u306a\u308b\u304b\u3092\u76ee\u306e\u5f53\u305f\u308a\u306b\u3057\u3066\u304d\u305f\u3002.<\/p><p>ITP\u306f\u60a3\u8005\u306b\u3088\u3063\u3066\u75c7\u72b6\u306b\u5927\u304d\u306a\u3070\u3089\u3064\u304d\u304c\u3042\u308b\u3002\u65e2\u5b58\u306eITP\u6cbb\u7642\u306b\u53cd\u5fdc\u3059\u308b\u60a3\u8005\u304c\u3044\u308b\u4e00\u65b9\u3067\u3001\u75c5\u72b6\u304c\u60aa\u5316\u3057\u305f\u308a\u3001\u518d\u767a\u3057\u305f\u308a\u3001\u3042\u308b\u3044\u306f\u5229\u7528\u53ef\u80fd\u306a\u6cbb\u7642\u6cd5\u3078\u306e\u53cd\u5fdc\u304c\u9650\u5b9a\u7684\u3060\u3063\u305f\u308a\u3059\u308b\u60a3\u8005\u3082\u3044\u308b\u3002\u3053\u306e\u305f\u3081\u3001\u7570\u306a\u308b\u4f5c\u7528\u6a5f\u5e8f\u3092\u6301\u3064ITP\u306e\u6cbb\u7642\u6cd5\u304c\u5fc5\u8981\u3068\u3055\u308c\u3066\u3044\u308b\u3002\u79c1\u306f\u3001\u6cbb\u7642\u3092\u8a66\u3057\u7d9a\u3051\u3066\u3044\u308b\u60a3\u8005\u3092\u6570\u591a\u304f\u898b\u3066\u304d\u305f\u3002.<\/p><p>HUTCHMED\u793e\u306b\u3088\u308b\u3068\u3001ITP\u306e\u63a8\u5b9a\u767a\u75c7\u7387\u306f\u6210\u4eba10\u4e07\u4eba\u3042\u305f\u308a3.3\u4f8b\u3001\u6709\u75c5\u7387\u306f\u6210\u4eba10\u4e07\u4eba\u3042\u305f\u308a9.5\u4f8b\u3067\u3042\u308b\u3002 \u3053\u308c\u3089\u306e\u63a8\u8a08\u306b\u57fa\u3065\u304f\u3068\u3001\u7c73\u56fd\u3001\u30c9\u30a4\u30c4\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u3001\u82f1\u56fd\u3001\u65e5\u672c\u306b\u306f5\u4e076,000\u4eba\u306eITP\u60a3\u8005\u304c\u304a\u308a\u3001\u3055\u3089\u306b\u4e2d\u56fd\u306b\u306f\u63a8\u8a0811\u4e07\u4eba\u306e\u60a3\u8005\u304c\u3044\u308b\u3002\u3053\u308c\u3089\u306e\u6570\u5b57\u306f\u3001\u591a\u304f\u306e\u5bb6\u65cf\u304c\u5f71\u97ff\u3092\u53d7\u3051\u3066\u3044\u308b\u3053\u3068\u3092\u610f\u5473\u3059\u308b\u3068\u805e\u3044\u3066\u3044\u308b\u3002.<\/p><p>\u3053\u308c\u3089\u306e\u6570\u5024\u306f\u3001ITP\u306e\u4e3b\u8981\u306a\u533b\u85ac\u54c1\u5e02\u5834\u306b\u304a\u3044\u3066\u3001\u65b0\u3057\u3044\u6cbb\u7642\u6cd5\u304c\u3044\u304b\u306b\u91cd\u8981\u3067\u3042\u308b\u304b\u3092\u6d6e\u304d\u5f6b\u308a\u306b\u3057\u3066\u3044\u308b\u3002\u3057\u304b\u3057\u3001ITP\u306e\u627f\u8a8d\u6e08\u307f\u533b\u85ac\u54c1\u306e\u9069\u7528\u5bfe\u8c61\u3068\u306a\u308b\u6700\u7d42\u7684\u306a\u60a3\u8005\u96c6\u56e3\u306f\u3001\u305d\u306e\u627f\u8a8d\u3055\u308c\u305f\u9069\u5fdc\u75c7\u3001\u81e8\u5e8a\u7684\u30a8\u30d3\u30c7\u30f3\u30b9\u3001\u304a\u3088\u3073\u73fe\u5730\u306e\u6cbb\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u3088\u3063\u3066\u6c7a\u307e\u308b\u3053\u3068\u306b\u306a\u308b\u3002\u79c1\u306f\u3001\u60a3\u8005\u4e00\u4eba\u3072\u3068\u308a\u306b\u5408\u308f\u305b\u305f\u6cbb\u7642\u3092\u884c\u3046\u3053\u3068\u304c\u4e0d\u53ef\u6b20\u3060\u3068\u8003\u3048\u3066\u3044\u308b\u3002.<\/p><h3>\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u306e\u958b\u767a\u72b6\u6cc1\u3068\u898f\u5236\u4e0a\u306e\u4f4d\u7f6e\u3065\u3051<\/h3><p>\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u306f\u3001\u7d30\u80de\u5185\u3067\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u3092\u52a9\u3051\u308b\u30bf\u30f3\u30d1\u30af\u8cea\u3067\u3042\u308bSyk\u3092\u6a19\u7684\u3068\u3059\u308b\u3002ITP\u3067\u306f\u3001Syk\u306b\u3088\u308b\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u304c\u514d\u75ab\u7cfb\u306b\u3088\u308b\u8840\u5c0f\u677f\u306e\u7834\u58ca\u3092\u52a9\u9577\u3059\u308b\u3002\u7814\u7a76\u8005\u305f\u3061\u306f\u3001\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u3092\u7528\u3044\u3066\u3053\u306e\u7d4c\u8def\u3092\u963b\u5bb3\u3059\u308b\u3053\u3068\u304c\u3001ITP\u306e\u7ba1\u7406\u306b\u3069\u306e\u3088\u3046\u306b\u5f79\u7acb\u3064\u304b\u306b\u3064\u3044\u3066\u7814\u7a76\u3092\u9032\u3081\u3066\u3044\u308b\u3002.<\/p><p>HUTCHMED\u793e\u306b\u3088\u308b\u3068\u3001ITP\u304a\u3088\u3073\u6e29\u6297\u4f53\u6027\u81ea\u5df1\u514d\u75ab\u6027\u6eb6\u8840\u6027\u8ca7\u8840\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u958b\u767a\u4e2d\u306e\u30bd\u30d6\u30ec\u30d7\u30ec\u30cb\u30d6\u306b\u95a2\u3059\u308b\u7533\u8acb\u304c\u3001\u4e2d\u56fd\u56fd\u5bb6\u85ac\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u306b\u3088\u3063\u3066\u5be9\u67fb\u4e2d\u3067\u3042\u308b\u3002\u3053\u308c\u3089\u306e\u7533\u8acb\u306f\u3001\u540c\u793e\u304c\u5b9f\u65bd\u3057\u305f\u81e8\u5e8a\u8a66\u9a13\u300cESLIM-01\u300d\u304a\u3088\u3073\u300cESLIM-02\u300d\u306e\u30c7\u30fc\u30bf\u306b\u57fa\u3065\u3044\u3066\u3044\u308b\u3002.<\/p><p>\u540c\u793e\u306f\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u306e\u6a29\u5229\u3092\u4fdd\u6709\u3057\u3066\u3044\u308b\u3002FDA\u306f\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u306b\u5e0c\u5c11\u75be\u60a3\u6307\u5b9a\u3092\u4e0e\u3048\u3001\u3053\u308c\u306b\u3088\u308a\u7c73\u56fd\u3067\u306f\u4e00\u5b9a\u306e\u512a\u9047\u63aa\u7f6e\u304c\u53d7\u3051\u3089\u308c\u308b\u3002\u3068\u306f\u3044\u3048\u3001\u7c73\u56fd\u3067ITP\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u3092\u8ca9\u58f2\u3059\u308b\u306b\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u3084\u898f\u5236\u5f53\u5c40\u306e\u627f\u8a8d\u304c\u307e\u3060\u5fc5\u8981\u3060\u3002.<\/p><p>\u3053\u306e\u9055\u3044\u306f\u3001\u6295\u8cc7\u5bb6\u3001\u533b\u5e2b\u3001\u305d\u3057\u3066\u60a3\u8005\u306b\u3068\u3063\u3066\u91cd\u8981\u3060\u3002\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u306f\u3001\u958b\u767a\u3092\u5f8c\u62bc\u3057\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308b\u3002\u305f\u3060\u3057\u3001\u627f\u8a8d\u3084\u5e02\u5834\u3067\u306e\u6210\u529f\u3001\u3042\u308b\u3044\u306f\u7279\u5b9a\u306e\u6cbb\u7642\u6210\u679c\u3092\u4fdd\u8a3c\u3059\u308b\u3082\u306e\u3067\u306f\u306a\u3044\u3002.<\/p><h3>\u65e5\u672c\u306e\u88fd\u85ac\u696d\u754c\u3078\u306e\u5f71\u97ff<\/h3><p>\u3053\u306e\u767a\u8868\u306f\u3001\u65e5\u672c\u306e\u88fd\u85ac\u30fb\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u696d\u754c\u306b\u3082\u5f71\u97ff\u3092\u53ca\u307c\u3059\u3002FDA\u306e\u6c7a\u5b9a\u306f\u7c73\u56fd\u306e\u5236\u5ea6\u306b\u9069\u7528\u3055\u308c\u308b\u3082\u306e\u3060\u304c\u3001\u305d\u306e\u6839\u5e95\u306b\u3042\u308b\u958b\u767a\u6226\u7565\u306f\u3001\u5e0c\u5c11\u75be\u60a3\u3084\u5c02\u9580\u7684\u306a\u6cbb\u7642\u6cd5\u306b\u53d6\u308a\u7d44\u3080\u4f01\u696d\u306b\u3068\u3063\u3066\u3082\u53c2\u8003\u306b\u306a\u308b\u3082\u306e\u3060\u3002.<\/p><p>\u65e5\u672c\u306b\u306f\u78ba\u7acb\u3055\u308c\u305f\u533b\u85ac\u54c1\u5e02\u5834\u304c\u3042\u308a\u3001\u591a\u304f\u306e\u60a3\u8005\u304cITP\u306b\u82e6\u3057\u3093\u3067\u3044\u308b\u3088\u3046\u3060\u3002\u6301\u7d9a\u6027ITP\u306e\u60a3\u8005\u306b\u6709\u52b9\u6027\u304c\u793a\u3055\u308c\u3066\u3044\u308b\u65b0\u3057\u3044\u6cbb\u7642\u6cd5\u306f\u3001\u78ba\u56fa\u305f\u308b\u81e8\u5e8a\u7684\u6839\u62e0\u304c\u3042\u308a\u3001\u65e5\u672c\u306e\u533b\u85ac\u54c1\u533b\u7642\u6a5f\u5668\u7dcf\u5408\u6a5f\u69cb\uff08PMDA\uff09\u306e\u627f\u8a8d\u3092\u5f97\u3089\u308c\u308c\u3070\u3001\u6700\u7d42\u7684\u306b\u306f\u60a3\u8005\u306e\u9078\u629e\u80a2\u3092\u5e83\u3052\u308b\u3082\u306e\u306b\u306a\u308b\u3068\u8003\u3048\u3066\u3044\u308b\u3002.<\/p><p>\u79c1\u306b\u3068\u3063\u3066\u3001\u3053\u306e\u4e8b\u4f8b\u306f\u3001\u88fd\u85ac\u4f01\u696d\u304c\u7279\u5b9a\u306e\u60a3\u8005\u5c64\u3092\u5bfe\u8c61\u3068\u3057\u305f\u533b\u85ac\u54c1\u3092\u958b\u767a\u3057\u3001\u591a\u304f\u306e\u5e02\u5834\u3092\u7db2\u7f85\u3059\u308b\u898f\u5236\u5bfe\u5fdc\u8a08\u753b\u306b\u5f93\u3046\u3053\u3068\u304c\u3044\u304b\u306b\u91cd\u8981\u304b\u3092\u793a\u3057\u3066\u3044\u308b\u3002\u307e\u305f\u3001\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u306b\u5bfe\u3059\u308b\u512a\u9047\u63aa\u7f6e\u306f\u3001\u958b\u767a\u30b3\u30b9\u30c8\u306e\u4e00\u90e8\u3092\u524a\u6e1b\u3057\u3001\u30e1\u30ea\u30c3\u30c8\u3092\u3082\u305f\u3089\u3059\u53ef\u80fd\u6027\u304c\u3042\u308b\u304c\u3001\u75be\u60a3\u306e\u7814\u7a76\u306f\u79d1\u5b66\u7684\u306b\u3082\u8ca1\u653f\u7684\u306b\u3082\u4f9d\u7136\u3068\u3057\u3066\u4e0d\u78ba\u5b9f\u6027\u3092\u4f34\u3046\u3002.<\/p><p>\u3053\u306e\u767a\u8868\u306f\u3001\u533b\u85ac\u54c1\u958b\u767a\u306b\u304a\u3051\u308b\u898f\u5236\u4e0a\u306e\u7d4c\u8def\u306e\u5f79\u5272\u3082\u793a\u3057\u3066\u3044\u308b\u3002\u3042\u308b\u5e02\u5834\u3067\u306e\u6307\u5b9a\u306f\u3001\u4f01\u696d\u306e\u958b\u767a\u8a08\u753b\u3092\u5f8c\u62bc\u3057\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308b\u304c\u3001\u305d\u308c\u304c\u81ea\u52d5\u7684\u306b\u4ed6\u306e\u7ba1\u8f44\u533a\u57df\u306b\u9069\u7528\u3055\u308c\u308b\u308f\u3051\u3067\u306f\u306a\u3044\u3002\u5c06\u6765\u3001\u65e5\u672c\u3067\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u304c\u5229\u7528\u53ef\u80fd\u306b\u306a\u308b\u304b\u3069\u3046\u304b\u306f\u3001\u65e5\u672c\u306e\u898f\u5236\u30d7\u30ed\u30bb\u30b9\u304a\u3088\u3073\u5f53\u5c40\u306b\u63d0\u51fa\u3055\u308c\u308b\u8a3c\u62e0\u6b21\u7b2c\u3068\u306a\u308b\u3002.<\/p><h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/\" rel=\"bookmark\">\u30ea\u30ba\u30e0\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u3001\u8996\u5e8a\u4e0b\u90e8\u6027\u80a5\u6e80\u6cbb\u7642\u85ac\u300cIM CIVREE\u300d\u3092\u65e5\u672c\u3067\u767a\u58f2\u3057\u305f<\/a><\/h4><p>\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306b\u3068\u3063\u3066\u3001\u7279\u5b9a\u306e\u75be\u60a3\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u3001\u672a\u5145\u8db3\u306e\u533b\u7642\u30cb\u30fc\u30ba\u306b\u5fdc\u3048\u3001\u72ec\u81ea\u306e\u533b\u85ac\u54c1\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u3092\u62e1\u5927\u3059\u308b\u6a5f\u4f1a\u3092\u3082\u305f\u3089\u3059\u3002\u898f\u5236\u4e0a\u306e\u512a\u9047\u63aa\u7f6e\u306b\u3088\u308a\u3001\u958b\u767a\u30b3\u30b9\u30c8\u3092\u524a\u6e1b\u3067\u304d\u308b\u53ef\u80fd\u6027\u304c\u3042\u308b\u3002\u3068\u306f\u3044\u3048\u3001\u4f01\u696d\u306f\u4f9d\u7136\u3068\u3057\u3066\u3001\u533b\u85ac\u54c1\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u3092\u793a\u3059\u81e8\u5e8a\u8a66\u9a13\u306e\u8cbb\u7528\u3092\u8ca0\u62c5\u3057\u3001\u88fd\u9020\u30fb\u8ca9\u58f2\u306b\u5411\u3051\u305f\u6e96\u5099\u3092\u6574\u3048\u306a\u3051\u308c\u3070\u306a\u3089\u306a\u3044\u3002.<\/p><p>\u533b\u7642\u5f93\u4e8b\u8005\u306b\u3068\u3063\u3066\u3001\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u304c\u3069\u308c\u307b\u3069\u6709\u7528\u3067\u3042\u308b\u304b\u306f\u3001\u5c06\u6765\u7684\u306a\u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u3088\u3063\u3066\u3001\u73fe\u5728\u306e\u9078\u629e\u80a2\u3068\u6bd4\u8f03\u3057\u3066\u5229\u76ca\u3068\u30ea\u30b9\u30af\u306e\u30d0\u30e9\u30f3\u30b9\u304c\u53d6\u308c\u3066\u3044\u308b\u304b\u3069\u3046\u304b\u304c\u793a\u3055\u308c\u308b\u304b\u3069\u3046\u304b\u306b\u304b\u304b\u3063\u3066\u3044\u308b\u3002\u60a3\u8005\u306f\u3001\u898f\u5236\u5f53\u5c40\u306e\u627f\u8a8d\u8868\u793a\u304c\u3042\u308b\u304b\u3089\u3068\u3044\u3063\u3066\u5b9f\u9a13\u7684\u306a\u85ac\u5264\u3092\u4f7f\u7528\u3059\u3079\u304d\u3060\u3068\u8003\u3048\u308b\u306e\u3067\u306f\u306a\u304f\u3001\u6cbb\u7642\u6cd5\u306e\u9078\u629e\u306b\u3064\u3044\u3066\u306f\u5f15\u304d\u7d9a\u304d\u533b\u5e2b\u3092\u4fe1\u983c\u3059\u3079\u304d\u3060\u3002.<\/p><p>HUTCHMED\u306e\u767a\u8868\u306f\u3001ITP\u306b\u5bfe\u3059\u308b\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u306e\u6709\u52b9\u6027\u306b\u304a\u3044\u3066\u9032\u5c55\u304c\u898b\u3089\u308c\u305f\u3053\u3068\u3092\u793a\u3057\u3066\u3044\u308b\u3002\u6b21\u306e\u91cd\u8981\u306a\u30b9\u30c6\u30c3\u30d7\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u3084\u3001\u7c73\u56fd\u3084\u305d\u306e\u4ed6\u306e\u5730\u57df\u3067\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u304c\u627f\u8a8d\u3092\u5f97\u308b\u306e\u306b\u5341\u5206\u306a\u8a3c\u62e0\u3092\u63d0\u793a\u3067\u304d\u308b\u304b\u3069\u3046\u304b\u3092\u78ba\u8a8d\u3059\u308b\u306a\u3069\u306e\u898f\u5236\u4e0a\u306e\u624b\u7d9a\u304d\u3060\u3002.<\/p><p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>The US Food and Drug Administration has given Orphan Drug Designation to sovleplenib, for treatment of thrombocytopenia or ITP. HUTCHMED Limited announced this decision on October 28 2026. ITP is a condition that causes platelet counts and increases the risk of bleeding.Sovleplenib is a drug being developed by HUTCHMED. It is an oral inhibitor of spleen tyrosine kinase or Syk. The drug is designed to be taken a day. The Orphan Drug Designation is a milestone in the development of sovleplenib.The FDA&rsquo;s Orphan Drug Designation program helps promote the development of medicines for diseases. These are conditions affecting than 200,000 people in the United States. The designation does not mean [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":40769,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[89,8098,182],"tags":[16604,14505,16605,346,575],"ppma_author":[572],"class_list":["post-40744","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-tech","category-news-articles","category-pharma","tag-drug-designation","tag-fda","tag-hutchmed","tag-manufacturing","tag-pharmaceutical"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HUTCHMED Announces FDA Designation for Sovleplenib<\/title>\n<meta name=\"description\" content=\"HUTCHMED announces that sovleplenib has received US FDA orphan drug designation for primary immune thrombocytopenia.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HUTCHMED Announces FDA Designation for Sovleplenib\" \/>\n<meta property=\"og:description\" content=\"HUTCHMED announces that sovleplenib has received US FDA orphan drug designation for primary immune thrombocytopenia.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-29T11:34:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/10\/HUTCHMED-Announces-Sovleplenib-Granted-US-FDA-Orphan-Drug-Designation-for-Primary-Immune-Thrombocytopenia.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"5\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HUTCHMED\u3001\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u306b\u3064\u3044\u3066FDA\u306e\u6307\u5b9a\u3092\u53d7\u3051\u305f\u3053\u3068\u3092\u767a\u8868","description":"HUTCHMED\u306f\u3001\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u304c\u539f\u767a\u6027\u514d\u75ab\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u306b\u5bfe\u3057\u3001\u7c73\u56fdFDA\u304b\u3089\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u305f\u3068\u767a\u8868\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/","og_locale":"ja_JP","og_type":"article","og_title":"HUTCHMED Announces FDA Designation for Sovleplenib","og_description":"HUTCHMED announces that sovleplenib has received US FDA orphan drug designation for primary immune thrombocytopenia.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/","og_site_name":"itbusinesstoday","article_published_time":"2026-10-29T11:34:09+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/10\/HUTCHMED-Announces-Sovleplenib-Granted-US-FDA-Orphan-Drug-Designation-for-Primary-Immune-Thrombocytopenia.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"5\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"HUTCHMED Wins FDA Orphan Drug Status for Sovleplenib","datePublished":"2026-10-29T11:34:09+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/"},"wordCount":914,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/10\/HUTCHMED-Announces-Sovleplenib-Granted-US-FDA-Orphan-Drug-Designation-for-Primary-Immune-Thrombocytopenia.webp","keywords":["Drug Designation","FDA","HUTCHMED","Manufacturing","pharmaceutical"],"articleSection":["Health Tech","News Articles","Pharma"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/","name":"HUTCHMED\u3001\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u306b\u3064\u3044\u3066FDA\u306e\u6307\u5b9a\u3092\u53d7\u3051\u305f\u3053\u3068\u3092\u767a\u8868","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/10\/HUTCHMED-Announces-Sovleplenib-Granted-US-FDA-Orphan-Drug-Designation-for-Primary-Immune-Thrombocytopenia.webp","datePublished":"2026-10-29T11:34:09+00:00","description":"HUTCHMED\u306f\u3001\u30bd\u30f4\u30ec\u30d7\u30ec\u30cb\u30d6\u304c\u539f\u767a\u6027\u514d\u75ab\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u306b\u5bfe\u3057\u3001\u7c73\u56fdFDA\u304b\u3089\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u305f\u3068\u767a\u8868\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/10\/HUTCHMED-Announces-Sovleplenib-Granted-US-FDA-Orphan-Drug-Designation-for-Primary-Immune-Thrombocytopenia.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/10\/HUTCHMED-Announces-Sovleplenib-Granted-US-FDA-Orphan-Drug-Designation-for-Primary-Immune-Thrombocytopenia.webp","width":1200,"height":800,"caption":"HUTCHMED"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/hutchmed-wins-fda-orphan-drug-status-for-sovleplenib\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"HUTCHMED Wins FDA Orphan Drug Status for Sovleplenib"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/40744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=40744"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/40744\/revisions"}],"predecessor-version":[{"id":40745,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/40744\/revisions\/40745"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/40769"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=40744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=40744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=40744"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=40744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}